z-logo
Premium
Purification and characterization of human platelet von Willebrand factor
Author(s) -
Williams Sybil B.,
McKeown Laurie P.,
Krutzsch Henry,
Hansmann Kristin,
Gralnick Harvey R.
Publication year - 1994
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1994.tb05077.x
Subject(s) - platelet , ristocetin , von willebrand factor , chemistry , thrombin , platelet activation , platelet lysate , biochemistry , platelet membrane glycoprotein , microbiology and biotechnology , medicine , biology
Summary. Platelet von Willebrand factor (vWf) was purified from human platelet concentrates. The multimeric structure of the purified platelet vWf was similar to that observed in the initial platelet lysate, and, like the platelet lysate, the purified platelet vWf contained higher molecular weight multimers than plasma vWf. The apparent molecular weight of the reduced platelet vWf subunit was similar to the plasma vWf subunit. The N‐terminal amino acid of the purified platelet and plasma vWf was blocked. In concentration dependent binding to botrocetin‐ or ristocetin‐stimulated platelets, 125 I‐plasma vWf bound with a higher affinity than platelet. The ristocetin cofactor activity per mg of purified plasma vWf was 5‐fold greater than the platelet vWf activity. Platelet and plasma vWf bound to collagen with similar affinities; however, platelet vWf bound to thrombin‐stimulated platelets and to heparin with a higher affinity than plasma vWf. The differences in the binding affinity(s) of plasma and platelet vWf to platelet GPIb and GPIIb/IIIa and extracellular matrix proteins may reflect different roles for plasma and platelet vWf in the initial stages of haemostasis and thrombosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here